AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ABACAVIR AND LAMIVUDINE
11 registrations across 3 African markets— 8 active
Markets with ABACAVIR AND LAMIVUDINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Abacavir and Lamivudine Tablets USP 600 mg/300 mg Film-Coated Tablet | 🇰🇪Kenya | Macleods Pharmaceuticals Limited | active | Feb 2028 |
| ABACAVIR_AND_LAMIVUDINE 600/300MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ABACAVIR_&LAMIVUDINE_DT 120/60MG DISPERSIBLE TABLET DISPERSIBLE TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ABACAVIR+LAMIVUDINE_DT 120/60MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| Abacavil Sulfate and Lamivudine dispersible tablets Tablets | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
| Abacavir and Lamivudine tablets for oral suspension 120/60mg Tablets for Oral Suspension | 🇹🇿Tanzania | Cipla Limited | active | — |
| Abacavir (as sulfate) /Lamivudine Tablet Film Coated Tablet | 🇹🇿Tanzania | Sun Pharmaceutical Industries Ltd | active | — |
| Abacavir and Lamivudine Tablets | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
| ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE Tablets | 🇹🇿Tanzania | Cipla Limited | active | — |
| Abacavir (as Sulfate) USP and Lamivudine 120/60 Dispersible Tablets | 🇹🇿Tanzania | Cipla Limited | active | — |
| Abacavir Sulfate / Lamivudine Tablets 600mg/300mg Tablets | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
ABACAVIR AND LAMIVUDINE in Africa — Regulatory Overview
ABACAVIR AND LAMIVUDINE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Malawi, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.